Researchers have identified an enzyme that is absent in healthy colon tissue but abundant in colon cancer cells, according to a report in the Jan. 26 issue of the Journal of Biological Chemistry. The enzyme appears to drive the conversion of normal colon tissue into cancer by attaching sugar molecules, or glycans, to certain proteins in
The #1 Resource for Faecal Immunochemical Testing (FIT) in the UK and Eire
- [email protected]
- +44 (0) 23 8048 3000
Category: News
The NICE FIT Study is a pioneering new research project in Bowel Cancer Care that has been initiated by the department of Colorectal Surgery at Croydon University Hospital and RM Partners Accountable Cancer Network in South and West London. Evidence from studies conducted around the world has suggested that FIT could rule out bowel cancer
Thousands more people across Scotland will benefit from the roll-out of a new and easier Bowel Cancer screening test that can detect the disease at an earlier, more treatable stage.
The long awaited NICE Guidance DG30 on “Quantitative faecal immunochemical tests (FIT) to guide referral for colorectal cancer in primary care” was published in July 2017.
